Outcome of the Board meeting held on February 2, 2026 to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 1.6 pts more than its Edible Oil peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of Ambar Protein Industries Ltd met on February 2, 2026, and approved the unaudited financial results for the quarter and nine months ended December 31, 2025. The meeting lasted from 3:30 PM to 4:30 PM. The Limited Review Auditors' Report on the unaudited financial results was also noted. The actual financial figures were not included in this filing — only the outcome of the board meeting was disclosed. Investors will need to refer to the detailed financial results document for specific numbers on revenue, profit, margins, and other metrics.
This is a routine regulatory filing confirming that Q3 FY26 results have been approved by the Board. Since no financial numbers were shared in this particular document, there is no direct material impact on the stock price from this announcement alone. Shareholders should review the separately filed unaudited financial results for actual performance insights.